Youngho Seo

Lawrence Berkeley National Laboratory — United States

Medicine · Health Sciences

45h-index8.0kcitations726works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(246), Medical Imaging Techniques and Applications(172), Prostate Cancer Treatment and Research(171), Multiple Myeloma Research and Treatments(95), Chemical Synthesis and Analysis(93)

Publications726 total

Clinical Translation of Antibody Positron Emission Tomography for Cancer Imaging
Clinical Cancer Research·2025
Regioselective Glycosylation of Fluorine-18-Labeled Sorbitol for Enhanced Bacterial Detection In Vivo Using PET
JACS Au·2025· 1 citedOpen Access
Configurable γ Photon Spectrometer to Enable Precision Radioguided Tumor Resection
IEEE Transactions on Biomedical Circuits and Systems·2025Open Access
Dynamic PET imaging predicts broadly neutralizing antibody distribution and HIV prevention efficacy
2025Open Access
Figure S10 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S3 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S2 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S5 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S1 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S11 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Supplementary Data 1 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S4 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S6 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S7 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
EVALUATING THE FEASIBILITY OF COMPTON IMAGING FOR AC-225 IN TARGETED ALPHA THERAPY
International Journal of Particle Therapy·2025Open Access
Figure S8 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
Figure S9 from Treatment of Prostate Cancer with CD46-targeted <sup>225</sup>Ac Alpha Particle Radioimmunotherapy
2025Open Access
MCAQ-YOLO: Morphological Complexity-Aware Quantization for Efficient Object Detection with Curriculum Learning
arXiv (Cornell University)·2025Open Access
Broad-Energy Gamma-Ray Imaging of Radiopharmaceuticals Using a Collimated Compton Camera
2025
High-Energy Imaging Capability of a State-of-the-Art Full-Ring CZT SPECT/CT
2025
page 1 of 37Next →

Frequent Co-authors

Henry F. VanBrocklin(13), Jaewon Yang(8), Robert R. Flavell(7), Randall A. Hawkins(7), Seong Chan Jun(7), Benjamin L. Franc(6), Katherine K. Matthay(5), Spencer C. Behr(4), Shih-Ying Huang(4), Thomas A. Hope(4), Miguel Hernandez Pampaloni(3), Florian Wiesinger(3), Sandeep Kaushik(3), Dattesh Shanbhag(3), Peder E. Z. Larson(3), Bruce H. Hasegawa(3), K. Vijaya Sankar(3), Chaiti Ray(3), Pragati A. Shinde(3), Rahul Aggarwal(3)